Biblioteca Hospital 12 de Octubre
Vista normal Vista MARC Vista ISBD

Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease. [artículo]

Por: Bermejo Pareja, Félix [Neurología] | Villarejo Galende, Alberto [Neurología].
Colaborador(es): Servicio de Neurología-Neurofisiología.
Editor: Alzheimers Research & Therapy, 2013Descripción: 5(6):55.Recursos en línea: Acceso libre Resumen: The clinical features of Alzheimer's disease (AD) overlap with a number of other dementias and conclusive diagnosis is only achieved at autopsy. Accurate in-life diagnosis requires finding biomarkers suitable for early diagnosis, as well as for discrimination from other types of dementia. Mounting evidence suggests that AD-dependent processes may also affect peripheral cells. We previously reported that calmodulin (CaM) signaling is impaired in AD lymphoblasts. Here, we address the issue as to whether the assessment of CaM levels in peripheral cells could serve as a diagnostic biomarker. Methods: A total of 165 subjects were enrolled in the study, including
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
    valoración media: 0.0 (0 votos)
Tipo de ítem Ubicación actual Signatura Estado Fecha de vencimiento
Artículo Artículo PC14138 (Navegar estantería) Disponible

Formato Vancouver:
Esteras N, Alquézar C, de la Encarnación A, Villarejo A, Bermejo-Pareja F, Martín-Requero A. Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease. Alzheimers Res Ther. 2013 Nov 7;5(6):55.

PMID: 24499616

Contiene 48 referencias

The clinical features of Alzheimer's disease (AD) overlap with a number of other dementias and conclusive diagnosis is only achieved at autopsy. Accurate in-life diagnosis requires finding biomarkers suitable for early diagnosis, as well as for discrimination from other types of dementia. Mounting evidence suggests that AD-dependent processes may also affect peripheral cells. We previously reported that calmodulin (CaM) signaling is impaired in AD lymphoblasts. Here, we address the issue as to whether the assessment of CaM levels in peripheral cells could serve as a diagnostic biomarker. Methods: A total of 165 subjects were enrolled in the study, including

No hay comentarios para este ejemplar.

Ingresar a su cuenta para colocar un comentario.

Con tecnología Koha